High Risk Acute Myeloid Leukemia
specificAcute myeloid leukemia characterized by poor response to induction chemotherapy and poor long-term survival following treatment with consolidation chemotherapy.
16
Centers
14
Active Trials
—
Cancer Funding
Top Centers for High Risk Acute Myeloid Leukemia(16)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive High-Volume Research Center | 72.8 |
| 2 | Boston University Cancer CenterBoston, MA High-Volume Research Center | 72.8 |
| 3 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 55.9 |
| 4 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 55.9 |
| 5 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 55.9 |
| 6 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 55.9 |
| 7 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 55.9 |
| 8 | NCI Clinical Active Research Program | 55.9 |
| 9 | University of Illinois Cancer CenterChicago, IL Active Research Program | 55.9 |
| 10 | Cancer Center at IllinoisUrbana, IL Active Research Program | 55.9 |
| 11 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 55.9 |
| 12 | Active Research Program | 55.9 |
| 13 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 36.2 |
| 14 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive | 36.2 |
| 15 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 36.2 |
| 16 | BC CancerVancouver, BC | 36.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →